---
title: 'Senior Engineer/Manager, Device Development — Combination Products at Oruka Therapeutics'
canonical: 'https://feeny.ai/job/senior-engineer-manager-device-development-combination-products-oruka-9vxkzfje9s3m'
type: 'job'
last_seen: '2026-11-04'
---

# Senior Engineer/Manager, Device Development — Combination Products at Oruka Therapeutics

- **Company:** Oruka Therapeutics
- **Location:** Waltham, MA
- **Compensation:** $146k–$161k
- **Posted:** 2026-10-01
- **Last confirmed live:** 2026-11-04
- **Apply:** https://job-boards.greenhouse.io/oruka/jobs/5441819008

## Job description

About Us:

Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit [www.orukatx.com](http://www.orukatx.com)

As we build our core team, we're seeking top talent in different functional areas who are not just looking for a job, but an opportunity to be part of something bigger.  Someone who is passionate about making a difference and eager to contribute to establishing an engaged, inclusive, and positive company culture.

Job Title: Senior Engineer/Manager, Device Development — Combination Products

Location: Hybrid, Waltham, MA –Candidates will be required to be in-office 3 days/week.

Role Overview:

We are seeking a Sr. Engineer/Manager, Device Development to provide hands-on technical and program leadership for one or more platform combination device programs, including autoinjector, and prefilled-syringe within Oruka’s drug asset pipeline.

Working under the direction of the Director of Device Development, this role executes device engineering deliverables day to day and manages the tactical, working-level relationship with Oruka’s external device suppliers, vendors, and contract manufacturing (CDMO) partners.  Device platform strategy, executive supplier relationships, and MSAT/PIP ownership sit with the Director/Sr. Director of DP Manufacturing and Device Development.

Key Responsibilities:

Device Technical Leadership

- Serve as the day-to-day technical lead for one or more assigned combination device programs (autoinjector, prefilled-syringe-based, or on-body/wearable injector systems).
- Execute device design control deliverables: design inputs/outputs, Design History File (DHF) content, verification and validation protocols/reports, and risk management files per ISO 14971.
- Support human factors and usability engineering activities per IEC 62366-1 and FDA guidance, planning and running formative studies and supporting summative (validation) studies led by HFE/the Associate Director.
- Execute device platform standardization initiatives, evaluating component and process options at the program level.
- Review and disposition device engineering changes, non-conformances, and CAPAs for assigned programs.

Program & Project Management

- Own program timelines, budgets, and risk registers for assigned device development workstreams.
- Drive stage-gate deliverables and readiness reviews for assigned programs, in partnership with Combination Product and Program Management.
- Manage cross-functional project plans, track critical path, and flag schedule or technical risks to the Associate Director/Director.
- Report program status and risks in team and program reviews.

External Supplier, Vendor & CDMO Management

- Support selection and qualification of device component suppliers and device CDMOs/CMOs
- Own the day-to-day, working-level technical relationship with external partners — technical oversight of device design, tooling, process development, and scale-up execution.
- Support negotiation and administration of quality agreements, technical agreements, and statements of work.
- Execute technology transfer activities from development through commercial manufacturing, escalating strategic decisions as needed.
- Track supplier performance and quality metrics day to day and drive resolution of routine technical or quality issues.

MSAT & Manufacturing Support

- Provide MSAT leadership for clinical and commercial device and combination-product manufacturing, including engineering, clinical, PPQ, and commercial campaigns.
- Serve as Person-in-Plant, providing on-site technical oversight and rapid issue resolution.
- Partner with CMOs and internal teams to lead technology transfer, scale-up, investigations, deviations, CAPAs, and continuous process improvement.

Cross-Functional & Regulatory Collaboration

- Partner with Quality, Regulatory Affairs, CMC/Drug Product, Clinical Supply, and Supply Chain on device-related deliverables for assigned programs.
- Author and support device-related content for combination product regulatory submissions (IND, NDA/BLA, design dossiers).
- Support Commercial and Marketing on device user needs and post-launch lifecycle activities for assigned programs.

Qualifications:

Education

- BS or MS in Mechanical, Biomedical, or related Engineering discipline.

## Experience

- 5–7 years of relevant device development experience in pharmaceutical, biotech, or medical device industries.
- Direct, hands-on experience developing combination products (drug-device), such as autoinjectors, prefilled syringes, on-body/wearable injectors, or similar parenteral delivery systems.

Technical Expertise

Strong knowledge of:

- Design controls and applicable standards/regulations: ISO 13485, FDA 21 CFR Part 4 and Part 820 (QMSR), IEC 62366-1, ISO 11608, ISO11040, and ISO 14971 (risk management).
- Working with external device suppliers, vendors, and/or CDMOs on technical execution, tooling, process development, or manufacturing scale-up.
- 3D Modeling expertise using Solidworks or equivalent platform

Leadership & Collaboration

- Demonstrated project management skills, including timeline and risk management within a cross-functional, matrixed team.
- Strong written and verbal communication skills.
- Supplier relationship development and project leadership without direct reporting
- Team building skills a plus

## Preferred Qualifications

- Prior experience contributing to human factors/usability studies (formative or summative).
- Experience supporting a program from development through clinical or commercial launch.
- Exposure to device platform standardization efforts across multiple drug assets.
- Familiarity with injectable biologics and parenteral drug product development.
- Experience as (or supporting) a Person-in-Plant (PIP) during manufacturing campaigns.

Additional Requirements

- Ability to travel approximately 20–30%, including visits to device suppliers and CDMO/manufacturing sites in Asia, US and EU.

Compensation:

- An appropriate financial package will be developed for the successful candidate to include a competitive base salary and equity, with a performance-related bonus opportunity.
- The anticipated salary range for candidates, who will work in Waltham, MA is $146,000 to $161,000. The final salary offered to a successful candidate will be dependent on several factors that may include but are not limited to the type and length of experience within the job, type and length of experience within the industry, education, etc. Oruka is a multi-state employer and this salary range may not reflect positions that work in other states.

We're looking forward to hearing how you can contribute to our team and mission. Join us in shaping the future of our company and making a real impact every day. Salary Range for the Role $146,000—$161,000 USD

What We Offer:

- A chance to be part of a vibrant startup culture where your work can directly impact bringing new medicines to patients.
- Competitive salary and benefits package.
- A supportive and inclusive team environment where everyone is encouraged to bring their authentic selves to work.
- Opportunities for professional growth and development.

## About Oruka Therapeutics

## Company Overview
- **One-liner**: Oruka Therapeutics is a clinical-stage biotechnology company developing potentially best-in-class monoclonal antibodies with extended half-lives to transform the treatment of psoriasis and other chronic inflammatory skin diseases by enabling high rates of complete disease clearance with as few as one or two doses per year.
- **Entity Type**: Public (Nasdaq: ORKA)
- **Headquarters**: Waltham, Massachusetts, United States (with a second office in Menlo Park, California)
- **Founded**: Not publicly available
- **Founders**: Not publicly available (the company was formed as a spinout of Paragon Therapeutics, which discovered its antibody pipeline)

## Core Business
- **Primary industry**: Biotechnology – dermatology and inflammatory disease therapeutics
- **Target customers**: Patients with plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and other inflammatory conditions; physicians and healthcare providers; payers and health systems
- **Mission**: *“To offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year.”* [orukatx.com](https://orukatx.com/)

## Products & Services
- **ORKA-001**: An investigational monoclonal antibody targeting IL-23p19, engineered for extended circulation time. Designed as a potentially best-in-class therapy for moderate-to-severe plaque psoriasis, with the potential for dosing once or twice per year. Currently in Phase 2b clinical trial (EVERLAST-B). [orukatx.com](https://orukatx.com/our-pipeline/)
- **ORKA-002**: An investigational monoclonal antibody targeting IL-17A/F, also engineered for half-life extension. Aimed at psoriasis, psoriatic arthritis, and hidradenitis suppurativa, with potential dosing two to three times per year. Currently in Phase 1/2. [orukatx.com](https://orukatx.com/our-pipeline/)
- **ORKA-003**: A preclinical sequential combination regimen of ORKA-002 and ORKA-001, designed to deliver rapid responses with an ideal maintenance profile. [orukatx.com](https://orukatx.com/our-pipeline/)
- **ORKA-021**: Preclinical stage candidate (details not fully disclosed). [orukatx.com](https://orukatx.com/our-pipeline/)

## Market Standing
- **Valuation/Market Cap**: Not publicly available at this time (company went public via IPO; market cap fluctuates daily). Latest financial data should be obtained from SEC filings.
- **Key Metric**: As a clinical-stage public company, Oruka has no approved products yet. Funding and operational runway are funded by its IPO proceeds; exact amounts not provided in search results.
- **Notable Investors/Partners**: Discovery and engineering partner: Paragon Therapeutics (also parent of Apogee Therapeutics and Spyre Therapeutics). Investor base includes public market shareholders post-IPO.
- **Growth Signals**: 
  - Two co-lead programs advancing through clinical trials (Phase 1 data expected; Phase 2 ongoing).
  - Team expanding rapidly, with multiple job openings across scientific, clinical, and corporate functions.
  - Dual-location offices (Boston area and Bay Area) to attract top biotech talent.

## Competitive Advantages
- **Advanced antibody engineering**: Incorporates half-life extension technology (e.g., YTE mutations) to dramatically prolong circulation time, aiming for the longest dosing intervals in the class (1–2 doses per year vs. standard 4–12 times per year).
- **Proven mechanisms**: Targets IL-23p19 and IL-17A/F—validated, blockbuster pathways in psoriasis—but with enhanced pharmacokinetics to maximize efficacy and patient convenience.
- **Discovery engine**: Pipeline originated from Paragon Therapeutics, a proven antibody engineering shop that also spawned Apogee and Spyre, indicating a repeatable model for creating best-in-class molecules.
- **Focus on complete clearance**: Emphasizes “complete disease clearance” (e.g., PASI 100) as a goal, not just improvement—a higher bar than many current treatments.

## Strategic Focus
- **Near-term**: Generate Phase 1 safety and pharmacokinetics data for ORKA-001 and ORKA-002; advance EVERLAST-B (Phase 2b for ORKA-001) and ORCA-SURGE (Phase 2 for ORKA-002); initiate trials in additional indications (psoriatic arthritis, hidradenitis suppurativa).
- **Long-term**: Build a fully integrated biopharmaceutical company capable of commercializing novel biologics, potentially expanding beyond dermatology into other inflammatory diseases.
- **Organizational growth**: Aggressively hiring across all functions (clinical development, medical affairs, regulatory, CMC, finance, BD, etc.) to scale from early-stage to late-stage organization.

## Why Work Here
- **Mission-driven**: A chance to directly impact millions of patients living with chronic skin diseases—offering the potential for life-changing freedom from disease.
- **Startup culture with public-company resources**: Small, nimble team (“wear multiple hats”) but with the backing of a Nasdaq listing, equity grants, and competitive compensation.
- **Flexible work environment**: Remote-first policy with hybrid options (3 days/week) if located near Waltham, MA or Menlo Park, CA offices. [greenhouse.io](https://job-boards.greenhouse.io/oruka/jobs/5202407008)
- **Compensation & benefits**: Competitive base salary (e.g., Senior Scientific Communications Manager salary range $161k–$187k), equity, performance bonus, and professional development opportunities. [greenhouse.io](https://job-boards.greenhouse.io/oruka/jobs/5202407008)
- **Team culture**: Described as “vibrant startup culture,” “supportive and inclusive,” with emphasis on bringing “authentic selves to work.” Opportunities for growth in a fast-moving, high-autonomy environment.
- **Top-tier location**: Offices in both the Boston/Cambridge biotech hub and the Bay Area, giving employees access to two of the strongest life science ecosystems.

## Sources
1. [orukatx.com – Home](https://orukatx.com/)
2. [orukatx.com – Who We Are](https://orukatx.com/who-we-are/)
3. [orukatx.com – Pipeline](https://orukatx.com/our-pipeline/)
4. [orukatx.com – Join Us](https://orukatx.com/join-us/)
5. [greenhouse.io – Senior Scientific Communications Manager job posting](https://job-boards.greenhouse.io/oruka/jobs/5202407008)

## Other roles at Oruka Therapeutics

- [Manager, Clinical Data Management](https://feeny.ai/job/manager-clinical-data-management-oruka-therapeutics-remote-2s40n9dfy7z3)
- [Senior Manager, Clinical Supply Chain – Biologics](https://feeny.ai/job/senior-manager-clinical-supply-chain-biologics-oruka-therapeutics-waltham-qkhs36pe1jg1) — Waltham, MA
- [Associate Director, Biostatistics](https://feeny.ai/job/associate-director-biostatistics-oruka-therapeutics-menlo-park-c0nn31kzkjdv) — Menlo Park, CA / Waltham, MA
- [Director of Biostatistics](https://feeny.ai/job/director-of-biostatistics-oruka-therapeutics-menlo-park-p1gj4dc26c6d) — Menlo Park, CA / Waltham, MA
- [Medical Director, Clinical Development](https://feeny.ai/job/medical-director-clinical-development-oruka-therapeutics-waltham-90d1jacw6dyb) — Waltham, MA
- [Senior Medical Director, Pharmacovigilance and Safety](https://feeny.ai/job/senior-medical-director-pharmacovigilance-and-safety-oruka-therapeutics-waltham-gp7z8xyv17a8) — Waltham, MA
- [Pharmacovigilance Scientist](https://feeny.ai/job/pharmacovigilance-scientist-oruka-therapeutics-waltham-6sn2jm3x9as4) — Waltham, MA
- [Clinical Scientist, Clinical Development](https://feeny.ai/job/clinical-scientist-clinical-development-oruka-therapeutics-remote-18t9akrxe2tm)
- [Manager/Senior Manager of Statistical Programming](https://feeny.ai/job/manager-senior-manager-of-statistical-programming-oruka-therapeutics-waltham-t1q186jwkqt7) — Waltham, MA
- [Senior Manager/Associate Director Clinical Monitoring Strategy & Optimization](https://feeny.ai/job/senior-manager-associate-director-clinical-monitoring-strategy-optimization-fz8n0jqr0913) — Menlo Park, CA / Waltham, MA